CHMP approves 13 new drugs

13 new treatments have received a positive opinion from the CHMP’s February monthly meeting, while seven drugs have been approved in new indications.
The European Medicines Agency's headquarters in Amsterdam | Photo: Rob Acket/EMA
The European Medicines Agency's headquarters in Amsterdam | Photo: Rob Acket/EMA
by MIKKEL AABENHUS HEMMINGSEN, translated by daniel pedersen

The European Medicines Agency’s (EMA) expert committee, the CHMP, has given a positive opinion for 13 news drugs, following the committee’s February monthly meeting. This brings the year’s total up to 20 new drugs pending official approval, while 17 existing drugs can await indication expansions.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading